Recognizing AI's profound potential to accelerate development, enhance safety monitoring, and bring effective treatments to patients faster, the two agencies have proactively outlined a principles-based framework designed to foster innovation while upholding the non-negotiable pillars of patient safety, product efficacy, and regulatory integrity.
Following a public consultation period (until October 15, 2025), the Algerian Ministry of Health, Ministry of Pharmaceutical Industry, the National Pharmacovigilance and Materiovigilance Centre (CNPM), and the National Agency for Pharmaceutical Products (ANPP) have jointly issued the final Algerian Guide to Good Pharmacovigilance Practices (BPPV) – Version 2.0, December 2025.
On January 5, 2026, the landscape of weight management in America shifted with the broad availability of Novo Nordisk's Wegovy® (semaglutide) pill. As the first and only FDA-approved oral GLP-1 receptor agonist for chronic weight management, it represents a monumental shift from injectable therapy, promising to expand access and transform patient experience. However, with...
A new international study protocol, published by the World Health Organization (WHO) in 2025, lays the groundwork for a critical public health initiative: determining how often a rare blood disorder occurs in children across low- and middle-income countries (LMICs). The study focuses on thrombocytopenia—a condition characterized by abnormally low platelet counts that can lead...
Nutrivigilance is the systematic monitoring, assessment, and prevention of adverse effects related to the use of food supplements, fortified foods, and other nutritional products. It is the pharmacovigilance equivalent for the nutraceutical and functional food sector.
This document is the "EDA Renal Anaemia Guidance to Good Pharmacy Practice" (Code: EDREX:GU.CAP.Care.016, Version: 2025), issued by the Egyptian Drug Authority's Central Administration of Pharmaceutical Care. It serves as a comprehensive, evidence-based clinical practice guideline for the management of anemia in patients with Chronic Kidney Disease (CKD).
The health-related SDGs are a subset of the United Nations’ 17 Sustainable Development Goals (2015–2030) that specifically focus on improving global health outcomes. They are tracked under SDG 3: “Ensure healthy lives and promote well-being for all at all ages”, but also include health-related indicators from other SDGs (e.g., clean water, nutrition, gender equality).
Advancing Medication Safety Through Knowledge and Vigilance
